Discontinuing Beta-blocker therapy after an uncomplicated myocardial infarction (MI) was found to cause a persistent rise in ...

acute- and post-myocardial infarction, and congestive heart failure. However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions.

Heart failure with reduced ejection fraction (HFrEF) represents a significant global health burden, affecting over 64 million individuals and resulting in substantial morbidity and mortality, ...

Drug therapies for patients with acute heart failure syndromes (AHFS ... angiotensin-receptor blockers, β-blockers, and aldosterone antagonists, during the patient's hospital stay in an effort ...

Around 3,000 lives could be saved and 5,500 hospital admissions prevented each year by changes to how people are treated for heart failure, according to a watchdog. New draft guidelines from the ...

Thousands could be saved by making this small change to heart failure treatment - Giving medication up to a year earlier ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

New findings from the CONFIDENCE trial show that combination therapy with finerenone and empagliflozin leads to significantly ...

Heating the lower limbs before exercise has been found to significantly improve endurance in individuals with heart failure.

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

which is a risk factor for heart failure. This risk can be mitigated through managing RA and other lifestyle changes. Inflammation in rheumatoid arthritis (RA) primarily affects the joints ...

If you have heart failure, you may feel weak and fatigued during the day. The illness can also affect you during the night. Here’s what to do about it. Quality sleep allows the body to rest and ...